Financial Performance Overview

INDO-MIM LIMITED reported strong financial results for FY26 with standalone Profit After Tax of ₹5,489.79 million, representing a 36.05% YoY increase from ₹4,035.16 million in FY25. Basic Earnings Per Share stood at ₹11.38 (35.93% increase) while Diluted EPS was ₹11.18 (36.60% increase). Gross revenue grew 29.08% to ₹36,579.71 million, with PBT/Gross Revenue improving to 20.13% and PAT/Gross Revenue reaching 15.00%.

Exceptional Items and Profitability

The company recognized exceptional items totaling ₹780.36 million, primarily comprising impairment of goodwill (₹711.28 million) and property, plant and equipment (₹96.40 million) related to Conway Marsh & Garrett Technologies Limited, partially offset by a reversal of impairment for TRIAX Industries LLC (₹27.32 million).

Dividend Declarations and Capital Structure

The Board declared two interim dividends totaling ₹6.80 per share (₹3.50 first interim and ₹3.30 second interim), resulting in aggregate cash outflow of ₹3,292.25 million. The company's issued, subscribed and paid-up capital increased to ₹484.153 million following allotment of 2,122,300 equity shares to employees under the ESOP scheme at ₹1 per share, reducing promoters' shareholding from 92.21% to 91.81%.

Acquisition and Expansion Activities

INDO-MIM expanded through strategic acquisitions including Phoenix DeVentures II Inc (acquired May 2025 for ₹1,338.26 million) and incorporation of INDO-MIM Arms Components Private Limited (December 2025). The company also completed the Conway Marsh & Garrett Technologies Limited acquisition (July 2023) with deferred consideration of GBP 0.86 million paid during FY26.

Subsidiary Performance and Operations

Wholly owned subsidiaries reported mixed results: INDO-MIM INC (USA) generated revenue of $42.36 million with profit of $4.25 million, while TRIAX Industries LLC (USA) reported revenue of $25.88 million with loss of ($2.36 million). Conway Marsh Garrett Technologies Ltd (UK) recorded revenue of £3.01 million with loss of (£1.03 million), and the newly acquired Phoenix DeVentures II Inc reported revenue of $6.70 million with loss of ($2.90 million).

Debt Position and Financial Structure

Secured borrowings stood at ₹10,904.88 million (₹5,289.41 million non-current, ₹5,615.47 million current) across multiple rupee term loans (interest rates 6.73%-11.85%) and foreign currency term loans (USD rates 5.58%-6.43%, EURO rate 2.80%). The company maintained an ICRA rating of [ICRA]AA+ (Stable) for its term loans and cash credit facilities.

Foreign Exchange Exposure and Risk Management

The company had significant foreign exchange exposure with USD receivables of $42.10 million (₹3,985.05 million), USD payables of $8.12 million (₹768.38 million), and USD borrowings of $7.28 million (₹688.28 million). EURO receivables stood at €10.55 million (₹1,149.62 million) with EURO borrowings of €5.48 million (₹597.54 million).

Employee Benefits and ESOP Scheme

The ESOP 2024 scheme had 10.973 million options outstanding with 2.1358 million options vested and 2.1223 million exercised. ESOP expenses recognized amounted to ₹145.15 million. The gratuity plan showed a net defined benefit liability of ₹41.21 million with actuarial assumptions including discount rate of 7.27% and salary escalation of 13.00%.

Contingent Liabilities and Legal Matters

Tax and regulatory matters under dispute totaled approximately ₹2,274.49 million across Customs, Excise, GST, and Income Tax authorities. Additional contingent liabilities included corporate guarantee for INDO-MIM USA lease (₹1,198.00 million) and payable for acquisition business contingent consideration (₹760.00 million).

Accounting Policies and Compliance

The Group follows comprehensive accounting policies in accordance with Indian Accounting Standards (Ind AS) covering revenue recognition (applying "right to invoice" principle for mold-making services), employee benefits, share-based payments, taxation, financial instruments, leases, and fair value measurement. All audit reports contained no qualifications, reservations, or adverse remarks.

Corporate Governance and Regulatory Compliance

The company confirmed compliance with all applicable laws including Sexual Harassment Act, 2013 (no complaints received), and maintained proper board and committee meeting schedules (11 board meetings, 10 audit committee meetings). The 30th Annual General Meeting was scheduled for September 22, 2026, to consider adoption of financial statements and other agenda items.